TrialClinical breast cancer2012

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with advanced, hormone-responsive breast cancer.

Ewa Mrózek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.